TVT surgery | TOT surgery | p Value | |
---|---|---|---|
Number | 38 | 45 | |
Age | 59.8 ± 10.0 | 62.6 ± 11.2 | 0.237* |
BMI | 23.1 ± 2.4 | 24.6 ± 4.1 | 0.0477* |
Parity | 2.0 ± 0.8 | 2.0 ± 0.9 | 0.9241* |
Menopause | 28(73.7%) | 34(75.6%) | > .9999** |
POP | 7(18.4%) | 15(33.3%) | 0.2048** |
UUI | 9(23.7%) | 10(22.2%) | > .9999** |
post-hysterectomy | 5(13.2%) | 7(15.6%) | > .9999** |
Pad test (g) | 38.5 ± 36.6 | 37.8 ± 44.4 | 0.9479* |
maximum urine flow rate (ml/s) | 32.1 ± 13.4 | 30.7 ± 11.9 | 0.6509* |
average urine flow rate (ml/s) | 24.1 ± 11.0 | 22.4 ± 10.5 | 0.5044* |
voided volume (ml) | 299.5 ± 90.8 | 290.3 ± 85.8 | 0.6543* |
post-voiding residue (ml) | 15.9 ± 31.9 | 13.8 ± 25.3 | 0.7472* |
ICIQ-SF | 15.3 ± 4.2 | 13.6 ± 4.8 | 0.1162* |
observation period (day) | 121.6 ± 144 | 93.8 ± 94.9 | 0.3165* |